Role of protein kinase C (PKC) in agonist-induced μ-opioid receptor down-regulation: II. Activation and involvement of the α, ε, and ζ isoforms of PKC

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 594-604

  Kramer, H Kenneth ^a   Simon, Eric J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Down regulation; Isoenzyme; Protein kinase; Receptor; Second messenger

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHELERYTHRINE; DELTA OPIATE RECEPTOR; DIACYLGLYCEROL; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ISOENZYME; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NIMODIPINE; OPIATE ANTAGONIST; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TRITIUM;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANALGESICS; ANALGESICS, OPIOID; BIOLOGICAL TRANSPORT; CARCINOGENS; DIPRENORPHINE; DOWN-REGULATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE; ENKEPHALINS; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; ISOENZYMES; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; PHORBOL 12,13-DIBUTYRATE; PHORBOL ESTERS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; RECEPTORS, OPIOID, MU; SECOND MESSENGER SYSTEMS; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0032902147     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720594.x     Document Type: Article

References (74)

1. Berridge M. J. (1984) Inositol triphosphate and diacylglycerol as second messengers. Biochem. J. 220, 345-360.
2. Berridge M. J. (1993) Inositol triphosphate and calcium signalling. Nature 361, 315-325.
3. Breivogel C. S., Selley D. E., and Childers S. R. (1997) Acute and chronic effects of opioids on δ and μ receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. J. Neurochem. 68, 1462-1472.
4. Cai Y. C., Ma L., Fan G. H., Zhao J., Jiang L. Z., and Pei G. (1997) Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors. Mol. Pharmacol. 51, 583-587.
5. Cardell M., Bingren H., Wieloch T., Zivin J., and Saitoh T. (1990) Protein kinase C is translocated to cell membranes during cerebral ischemia. Neurosci. Lett. 119, 228-232.
6. Carter B. D. and Medzihradsky F. (1993) Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43, 465-473.
7. Castanga M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., and Nishizuka Y. (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor promoting phorbol esters. J. Biol. Chem. 257, 7847-7851.
8. Chen C. C., Cheng C. S., Chang J., and Huang H. C. (1995) Differential correlation between translocation and down-regulation of conventional and new protein kinase C isozymes in C6 glioma cells. J. Neurochem. 64, 818-824.
9. + channel. J. Biol. Chem. 269, 7839-7842.
10. Chen Y., Mestek A., Lui J., Hurley J. A., and Yu L. (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
11. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
12. Conn P. J. and Sanders-Bush E. (1985) Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J. Pharmacol. Exp. Ther. 234, 195-203.
13. Conn P. J. and Sanders-Bush E. (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J. Neurosci. 6, 3669-3675.
14. Connor M. and Henderson G. (1996) Delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117, 333-340.
15. 353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271, 4073-4076.
16. Evans C., Keith D., Morrison H., Magendzo K., and Edwards R. (1992) Cloning of a delta-opioid receptor by functional expression. Science 258, 1952-1955.
17. Fan G. H., Zhao J., Lou L. G., Jing Q., Ma L., and Pei G. (1998) N-Methyl-D-aspartate attenuates opioid receptor-mediated G-protein activation and this process involves protein kinase C. Mol. Pharmacol. 53, 684-690.
18. Favaron M., Manev H., Alho H., Bertolino M., Ferret B., Guidotti A., and Costa E. (1988) Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc. Natl. Acad. Sci. USA 85, 7351-7355.
19. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol. Mol. Pharmacol. 300, 173-181.
20. Gucker S. and Bidlack J. M. (1992) Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells. Mol. Pharmacol. 42, 656-665.
21. Herbert J. M., Augereau J. M., Gleye J., and Maffrand J. P. (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172, 993-999.
22. Hong D. H., Huan J., Ou B. R., Yeh J. Y., Saido T. C., Cheeke P. R., and Forsberg N. E. (1995) Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim. Biophys. Acta 1267, 45-54.
23. Jin W., Lee N. M., Loh H. H., and Thayer S. A. (1994) Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J. Neurosci. 14, 1920-1929.
24. Jones T., Courage C., Hubbard A., and Gescher A. (1997) Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues. Biochem. Pharmacol. 53, 1413-1418.
25. Keenan C., Kelleher D., and Long A. (1995) Regulation of nonclassical protein kinase C isoenzymes in a human T cell line. Eur. J. Immunol. 25, 13-17.
26. Kendall D. A. and Nahorski S. R. (1985) 5-HT-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J. Pharmacol. Exp. Ther. 233, 473-479.
27. Kieffer B., Befort K., Ruff C., and Hirth C. (1992) The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
28. Kramer H. K. and Simon E. J. (1999) Role of protein kinase C (PKC) in agonist-induced μ-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by μ-opioid agonists. J. Neurochem. 72, 585-593.
29. Kramer H. K., Poblete J. C., and Azmitia E. C. (1997) The activation of protein kinase C by 3,4-methylenedioxymethamphetamine (MDMA) occurs through stimulation of serotonin receptors and transporter. Neuropsychopharmacology 17, 117-129.
30. Lefkowitz R. J. (1993) G protein-coupled receptor kinases. Cell 74, 409-411.
31. Mahon T. M., Matthews J. S., and O'Neill L. A. (1997) Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergies with interleukin 1 alpha in EL4 thymoma cells. Biochem. J. 325, 39-45.
32. Manev H., Costa E., Wroblewski J. T., and Guidotti A. (1990) Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. FASEB J. 4, 2789-2797.
33. 2+-requiring proteinase. Proc. Natl. Acad. Sci. USA 82, 6435-6439.
34. Mullaney I., Carr C., Burt A., Wilson M., Anderson N. G., and Milligan G. (1997) Agonist-mediated tyrosine phosphorylation of isoforms of the Shc adapter protein by the δ-opioid receptor. Cell. Signal. 9, 423-429.
35. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
36. Nakanishi H. and Exton J. H. (1992) Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J. Biol. Chem. 267, 16347-16354.
37. Narita M., Feng Y., Makimura M., Hoskins B., and Ho I. K. (1994) A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur. J. Pharmacol. 271, 543-545.
38. Narita M., Mizoguchi H., Kampine J. P., and Tseng L. F. (1996) Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol. 118, 1829-1835.
39. Narita M., Ohsawa M., Mizoguchi H., Kamei J., and Tseng L. F. (1997) Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu-but not epsilon-opioid receptor agonist in the mouse. Neuroscience 76, 291-298.
40. Nestler E. J. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
41. Nishizuka Y. (1986) Studies and perspectives of protein kinase C. Science 233, 305-312.
42. Nishizuka Y. (1992) Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
43. O'Connell M. A., Kelleher D., Liskamp R. M., Hall N., O'Neill L. A., and Long A. (1997) TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes. Cytokine 9, 83-92.
44. Pei G., Kieffer B. L., Lefkowitz R. J., and Freedman N. J. (1995) Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
45. Polakiewicz R. D., Schieferl S. M., Dorner L. F., Kansra V., and Comb M. J. (1998) A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization. J. Biol. Chem. 273, 12402-12406.
46. Porzig H. (1990) Pharmacological modulation of voltage-dependent calcium channels in intact cells. Rev. Physiol. Biochem. Pharmacol. 114, 209-262.
47. Same Y. and Gafni M. (1996) Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG108-15 neuroblastoma. Brain Res. 722, 203-206.
48. Same Y., Fields A., Keren O., and Gafni M. (1996) Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem. Res. 21, 1351-1359.
49. Shen K. F., Crain S. M., and Ledeen R. W. (1991) Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 559, 130-138.
50. Simon E. J., Hiller J. M., Groth J., and Edelman I. (1975) Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. J. Pharmacol. Exp. Ther. 192, 531-537.
51. + currents. Br. J. Pharmacol. 116, 2655-2660.
52. Smart D. and Lambert D. G. (1995b) Mu-opioid activation of phospholipase C in SH-SY5Y cells rapidly desensitizes: mechanistic studies. (Abstr.) Biochem. Soc. Trans. 23, 419S.
53. 2+ from intracellular stores, in undifferentiated NG108-15 cells. J. Neurochem. 66, 1462-1467.
54. i, and adenylyl cyclase. Br. J. Pharmacol. 120, 1165-1171.
55. Tang T., Kiang J. G., and Cox B. M. (1994) Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells. J. Pharmacol. Exp. Ther. 270, 40-46.
56. Tippmer S., Quitterer U., Kolm V., Faussner A., Roscher A., Mosthaf L., Muller-Esterl W., and Haring H. (1994) Bradykinin induces translocation of the protein kinase C isoforms α, ∈, and ζ. Eur. J. Biochem. 225, 297-304.
57. 2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Eur. J. Pharmacol. 279, 93-98.
58. Tokuyama S., Feng Y., Wakabayashi H., and Ho I. K. (1995b) Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors. H-7 and H-8. Eur. J. Pharmacol. 284, 101-107.
59. Trapaidze N., Keith D. E., Cvejic S., Evans C. J., and Devi L. A. (1996) Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285.
60. Tsu R. C. and Wong Y. H. (1996) Gi-mediated stimulation of type II adenylyl cyclase is augmented by Gq-coupled receptor activation and phorbol ester treatment. J. Neurosci. 16, 1317-1323.
61. +- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Biochem. J. 297, 401-413.
62. Turner N. A., Walker J. H., Ball S. G., and Vaughan P. F. T. (1996) Downregulation or long-term inhibition of protein kinase C reduces noradrenaline release evoked via either PKC-dependent or PKC-independent pathways in human SH-SY5Y neuroblastoma cells. Neurosci. Lett. 220, 37-40.
63. Ueda H., Miyamae T., Fukushima N., Takeshima H., Fukuda K., Sasaki Y., and Misu Y. (1995a) Opioid mu- and kappa-receptors mediate phospholipase C activation through Gi1 in Xenopus oocytes. Brain Res. Mol. Brain Res. 32, 166-170.
64. Ueda H., Miyamae T., Hayashi C., Watanabe S., Fukushima N., Sasaki Y., Iwamura T., and Misu Y. (1995b) Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gi1-phospholipase C activation in Xenopus oocytes. J. Neurosci. 15, 7485-7499.
65. Wang J. B., Imia Y., Eppler C. M., Gregor P., Spivak C. E., and Uhl G. R. (1993) μ-Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90, 10230-10234.
66. Wang L., Medina V. M., Rivera M., and Gintzler A. R. (1996a) Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue. Brain Res. 723, 61-69.
67. 2+-dependent. FEBS Lett. 387, 53-57.
68. 2+ channels. J. Neurosci. 15, 4124-4132.
69. Winstel R., Freund S., Krasel C., Hoppe E., and Lohse M. (1996) Protein kinase cross-talk: membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc. Natl. Acad. Sci. USA 93, 2105-2109.
70. ++, phorbol ester, and ATP. J. Biol. Chem. 260, 15718-15722.
71. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T., and Bell G. I. (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90, 6736-6740.
72. Zadina J. E., Harrison L. M., Ge L. J., Kastin A. J., and Chang S. L. (1994) Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270, 1086-1096.
73. Zhang J., Ferguson S. S. G., Barak L. S., Bodduluri S. R., Laporte S. A., Law P.-Y., and Caron M. G. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95, 7157-7162.
74. Zhang L., Yu Y., Mackin S., Weight F. F., Uhl G. R., and Wang J. B. (1996) Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271, 11449-11454.